Skip to content

Clinical trials

Epilepsy trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Country / region: France Clear all

246 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20043
20059
20067
20077
20089
20094
20106
201117
20126
201313
20149
201516
201613
201711
20186
201915
20206
202117
202211
202313
202416
202517
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed132
Recruiting42
Unknown status28
Terminated25
Not yet recruiting8
Active, not recruiting7
Enrolling by invitation4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospices Civils de Lyon27
Assistance Publique - Hôpitaux de Paris18
Assistance Publique Hopitaux De Marseille17
UCB Pharma15
Fondation Ophtalmologique Adolphe de Rothschild9
University Hospital, Grenoble9
University Hospital, Toulouse9
Central Hospital, Nancy, France8
Eisai Inc.7
GlaxoSmithKline7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy246
Seizures52
Drug Resistant Epilepsy17
Epilepsies, Partial14
Epilepsies, Myoclonic11
Sudden Unexpected Death in Epilepsy9
Epilepsy, Temporal Lobe6
Parkinson Disease5
Brain Diseases4
Neurodevelopmental Disorders4

Trials

Showing 76 to 100 of 246. Each trial links to its page on Pharma Observatory.

146 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.